Bank of New York Mellon’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$46.9M Buy
638,722
+55,629
+10% +$4.08M 0.01% 1042
2025
Q1
$66.6M Sell
583,093
-6,678
-1% -$763K 0.01% 799
2024
Q4
$29.7M Sell
589,771
-15,637
-3% -$788K 0.01% 1333
2024
Q3
$28M Sell
605,408
-72,736
-11% -$3.37M 0.01% 1381
2024
Q2
$22M Sell
678,144
-45,878
-6% -$1.49M ﹤0.01% 1519
2024
Q1
$18.2M Sell
724,022
-48,732
-6% -$1.23M ﹤0.01% 1628
2023
Q4
$25.1M Sell
772,754
-62,073
-7% -$2.02M 0.01% 1476
2023
Q3
$22.7M Sell
834,827
-19,425
-2% -$529K 0.01% 1484
2023
Q2
$19M Sell
854,252
-73,659
-8% -$1.64M ﹤0.01% 1580
2023
Q1
$20.1M Buy
927,911
+14,059
+2% +$305K ﹤0.01% 1540
2022
Q4
$18.6M Sell
913,852
-84,940
-9% -$1.73M ﹤0.01% 1577
2022
Q3
$25.6M Buy
998,792
+38,453
+4% +$986K 0.01% 1356
2022
Q2
$22.8M Sell
960,339
-38,741
-4% -$921K 0.01% 1460
2022
Q1
$22.5M Sell
999,080
-34,622
-3% -$780K ﹤0.01% 1599
2021
Q4
$20.5M Sell
1,033,702
-57,883
-5% -$1.15M ﹤0.01% 1713
2021
Q3
$21.5M Buy
1,091,585
+9,659
+0.9% +$190K ﹤0.01% 1689
2021
Q2
$23.8M Sell
1,081,926
-317
-0% -$6.97K ﹤0.01% 1630
2021
Q1
$25.7M Sell
1,082,243
-1,598
-0.1% -$38K 0.01% 1554
2020
Q4
$28.4M Sell
1,083,841
-51,000
-4% -$1.33M 0.01% 1422
2020
Q3
$19.8M Sell
1,134,841
-21,894
-2% -$381K ﹤0.01% 1482
2020
Q2
$19.5M Sell
1,156,735
-6,127
-0.5% -$103K 0.01% 1459
2020
Q1
$13.8M Sell
1,162,862
-51,488
-4% -$612K ﹤0.01% 1516
2019
Q4
$14.7M Sell
1,214,350
-13,473
-1% -$163K ﹤0.01% 1745
2019
Q3
$17.4M Sell
1,227,823
-43,945
-3% -$621K ﹤0.01% 1614
2019
Q2
$14.2M Sell
1,271,768
-9,548
-0.7% -$106K ﹤0.01% 1763
2019
Q1
$15M Sell
1,281,316
-60,625
-5% -$712K ﹤0.01% 1737
2018
Q4
$17.9M Buy
1,341,941
+42,227
+3% +$564K 0.01% 1545
2018
Q3
$18.2M Buy
1,299,714
+101,762
+8% +$1.43M ﹤0.01% 1686
2018
Q2
$18.8M Buy
1,197,952
+11,001
+0.9% +$173K 0.01% 1638
2018
Q1
$19.5M Sell
1,186,951
-349,529
-23% -$5.75M 0.01% 1583
2017
Q4
$27.7M Buy
1,536,480
+587,457
+62% +$10.6M 0.01% 1381
2017
Q3
$18.3M Buy
949,023
+22,673
+2% +$438K 0.01% 1618
2017
Q2
$10.9M Buy
926,350
+41,703
+5% +$492K ﹤0.01% 1908
2017
Q1
$9.7M Buy
884,647
+434,080
+96% +$4.76M ﹤0.01% 1988
2016
Q4
$3.27M Buy
450,567
+110,889
+33% +$805K ﹤0.01% 2566
2016
Q3
$2.21M Buy
339,678
+18,806
+6% +$122K ﹤0.01% 2701
2016
Q2
$1.75M Buy
320,872
+49,807
+18% +$272K ﹤0.01% 2790
2016
Q1
$1.27M Sell
271,065
-12,004
-4% -$56.2K ﹤0.01% 2923
2015
Q4
$1.41M Buy
283,069
+12,664
+5% +$63.1K ﹤0.01% 2923
2015
Q3
$1.02M Sell
270,405
-54,564
-17% -$205K ﹤0.01% 3155
2015
Q2
$1.95M Buy
324,969
+76,999
+31% +$463K ﹤0.01% 2927
2015
Q1
$1.39M Sell
247,970
-11,820
-5% -$66.2K ﹤0.01% 3102
2014
Q4
$779K Sell
259,790
-16,892
-6% -$50.7K ﹤0.01% 3439
2014
Q3
$741K Sell
276,682
-781
-0.3% -$2.09K ﹤0.01% 3464
2014
Q2
$776K Buy
277,463
+26,616
+11% +$74.4K ﹤0.01% 3439
2014
Q1
$1.09M Buy
250,847
+11,096
+5% +$48.4K ﹤0.01% 3226
2013
Q4
$770K Buy
239,751
+8,683
+4% +$27.9K ﹤0.01% 3419
2013
Q3
$367K Buy
231,068
+755
+0.3% +$1.2K ﹤0.01% 3609
2013
Q2
$398K Buy
+230,313
New +$398K ﹤0.01% 3569